Skip to main content
. 2020 Feb 15;225(4):1193–1224. doi: 10.1007/s00429-020-02041-6

Fig. 3.

Fig. 3

Anterograde tracing: injection sites and labeling. a, b Case 2012-6 (rat). In the same surgical session, we injected PHA-L in the central caudate putamen (CPu) of the left (L) cerebral hemisphere, while contralaterally (R), we injected BDA in the caudal CPu. Note significant retrograde transport of BDA-to-cerebral cortical pyramidal neurons ipsilateral to the injection site (dashed ellipse). Injection sites measure approximately 1 mm in diameter. c Low-power fluorescence montage in case FS-95166: injection site of PHA-L in the central nucleus (CE) of the amygdaloid complex. Bmg magnocellular basal amygdaloid nucleus. d Low-magnification montage of a combination of PHA-L tracing and neurobiotin injection. PHA-L-labeled fibers (red; Cy3) in layers II–III of medial parahippocampal cortex in contact with apical dendrites of neurobiotin-labeled pyramidal cells (green) located deep (layer V). LD lamina dissecans. e Low magnification: combination of PHA-L tracing and AF555 intracellular injection. An apical dendrite of an intracellularly AF555 injected hippocampal CA1 pyramidal neuron (red) penetrating stratum lacunosum moleculare (LM) The latter contains a terminal field of PHA-L labeled fibers (Alexa Fluor® 488; green) belonging to the perforant pathway (PHA-L injected in medial parahippocampal cortex). SR stratum radiatum